Abstract
Introduction
As in obstructive sleep apnea (OSA), the chronic cycles of hypoxia and reoxygenation are thought to be conducive of oxidative stress (OS) with generation of reactive oxygen species, identifying effective mechanisms of protection against oxidant-mediated tissue damage becomes of outmost importance. Leptin’s role had been recently extended into that of participant to OS; while its exact role in this process is yet to be defined, elevated leptin levels correlate significantly with several indices of OSA disease severity such as nocturnal hypoxemia, possibly acting as a counteractive mechanism against the chronic intermittent hypoxia-related OS and serving as a marker of future risk of atherosclerotic disease. We therefore investigated leptin’s antioxidant mechanism on superoxide (O −•2 ) anions using spectrophotometry and electron paramagnetic resonance (EPR).
Methods
The O −•2 was generated by oxidation of xanthine (XAN) by xanthine oxidase (XO) in the presence of spin trap 5-diethoxyphosphoryl-5-methyl-1-pyrroline N-oxide with various concentrations of leptin (0.001, 0.01, 0.1, and 1 mg/ml) and without leptin. Signal intensity between 3,440 and 3,540 G was expressed as standard means ± SD. The activity of leptin on XO was determined by monitoring the conversion of XAN to uric acid at 293 nm using a Beckman DU 800 UV–visible spectrophotometer.
Results
Leptin added to aqueous solutions at 0.1 and 1 mg/ml concentrations was associated with a statistically significant decrease in the EPR signal due to leptin’s direct scavenging activity towards the O −•2 .
Conclusion
Leptin is an antioxidant agent of possible use as a marker of OS and future risk of atherosclerotic disease in OSA.
Similar content being viewed by others
Abbreviations
- ROS:
-
Reactive oxygen species
- O −•2 :
-
Superoxide anion radical
- XO:
-
Xanthine oxidase
- OSA:
-
Obstructive sleep apnea
- SOD:
-
Superoxide dismutase
- VEGF:
-
Vascular endothelial growth factor
- EPR:
-
Electron paramagnetic resonance
- XAN:
-
Xanthine
- DEPMPO:
-
5-Diethoxyphosphoryl-5-methyl-1-pyrroline N-oxide
- PBS:
-
Phosphate buffered saline
- SOD:
-
Superoxide dismutase
- GSH-P:
-
Glutathione peroxidase
- GSH-R:
-
Glutathione reductase
References
Ip M, Lam K, Ho C, Tsang KW, Lam W (2000) Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118:580–586
Wang M, Orci L, Ravazzola M, Unger RH (2005) Fat storage in adipocyte requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. P N A S 120:18011–18016
Zwillich C (1998) Sleep apnea and autonomic function. Thorax 53:S20–S24
Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904
Phipps PR, Starritt E, Caterson GRR (2002) Association of serum leptin and hypoventilation in human obesity. Thorax 57:75–76
O’Donnell CP, Schaub CD, Haines AS, Berkowitz DE, Tankersley CG, Schwartz AR, Smith PL (1999) Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 159:1477–1484
Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, Ohi M (1999) Changes in intraabdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706–712
Harsch IA, Konturek PC, Koebnick C (2003) Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22:251–257
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432
Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE, Jang Y, Cho SY, Kim HS (2001) Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33:95–102
Guerre-Millo M, Grosfeld A, Isaad T (2002) Leptin is a hypoxia-inducible gene. Obes Res 8:856
El Solh AA, Saliba R, Bobinski T, Grant BJ, Berbary E, Miller N (2006) Allopurinol improves endothelial function in sleep apnea: a randomized controlled study. Eur Resp J 4:997–1002
Lee-Chiong T (2006) Sleep: a comprehensive handbook. Wiley-Liss, New York
Christou K, Moulas AN, Pastaka C, Gourgoulianis KI (2003) Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4:225–228
Sainz N, Rodriguez A, Catalan V, Becerril S, Ramírez B, Gómez-Ambrosi J, Frühbeck G (2010) Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob/ob mice. Mediators Inflamm 2010:784343
Eguchi M, Liu YI, Shin EJ, Sweeney G (2008) Leptin protects H9c2 rat cardiomyocytes from H2O2-induced apoptosis. FASEB J 75:3136–3144
Zheng J, Fang J, Yin YJ, Wang X-C, Ren An-Jing, Bai J, Sun X-J, Yuan W-J, Lin L (2010) Leptin protects cardiomyocytes from serum deprivation induced apoptosis by increasing antioxidant defense. Clin Exp Pharmacol Physiol 37:955–962
Sanchez-de-la-Torre M, Mediano O, Barcelo A, Pierola J, de la Pena M, Esquinas C et al (2012) The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath (in press)
Lee SD, Ju G, Choi JA, Kim JW, Yoon IY (2012) The association of oxidative stress with central obesity in obstructive sleep apnea. PMID: 21614576
Phillips BG, Kato M, Narkiewicz K, Chloe I, Somers VK (2000) Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279:234–237
Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T (2005) Sleep oxygen desaturations and circulating leptin in obstructive sleep apnea–hypopnea syndrome. Chest 127:716–721
McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea. AJRCCM 175:190–195
Ozata M, Uckaya G, Aydin A, Isimer A, Ozdemir IC (2000) Defective antioxidant defense system in patients with a human leptin mutation. Horm Metab Res 37:269–272
Kohen R, Nyska A (2002) Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions and methods for their quantification. Toxicol Pathol 30:620–650
Floyd RA (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4:2587–2597
Pacher P, Nivorozhkin A, Szabo C (2006) Therapeutic effects of xanthine-oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58:87–114
Mackintosh RM, Hirsch J (2001) The effects of leptin administration in non-obese human subjects. Obes Res 8:462–469
Schulz C, Paulus K, Lehnert H (2004) Central nervous and metabolic effects of intranasally applied leptin. Endocrinology 6:2696–2701
Fridrich I (1970) Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J Biol Chem 245:4053–4057
Chabot F, Mitchell JA, Gutteridge JMC (1998) Reactive oxygen species in acute lung injury. Eur Respir J 11:745–757
Prasad K, Kalra J (1993) Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 125:958–973
Knight JA (2000) Review: free radicals, antioxidants, and the immune system. Ann Clin Lab Sci 30:145–158
Chen TI, Lai CJ, Hsieh CJ, Tsai KL, Yang KT (2011) Differences in left ventricular cardiomyocytes loss induced by chronic intermittent hypoxia between spontaneously hypertensive and Wistar–Kyoto rats. Seep Breath 15:845–854
Christou K, Markoulis N, Moulas A, Pastaka C, Gourgoulianis KI (2003) Reactive oxygen metabolites (ROMs) as index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 7:105–110
Schultz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Am J Respir Crit Care Med 162:566–570
Murri M, Garcia-Delgado R, Alcazar-Ramirez L, Fernández-Ramos A, Alcaide J, Cardona F, Tinahones F (2011) Continuous positive airway pressure treatment effect on oxidative stress and circulating progenitor cell levels in sleep patients with apnea–hypopnea syndrome. Respir Care, May, 20
Ip MSM, Lam B, Chan LY, Zheng L, Tsang KWT, Fung PC, Lam WK (2000) Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162:2166–2171
Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939
Hamarat M, Yenilmez A, Erkasap N, Burhanettin I, Erinc A, Tulay K, Cavit C, Canan BD (2010) Protective effects of leptin on ischemia/reperfusion injury in rat bladder. Chin J Physiol 43:145–150
Sanchez-Pozo C, Rodriguez-Bano J, Dominiguez-Castellano A (2003) Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients. Clin Exp Immunol 134:464–469
He WH, Li B, Zhu X (2010) The role and mechanism of NADPH oxidase in leptin-induced reactive oxygen species production in hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi 18:849–854
Jian-Xiong C, Yu H , Tuo Q, Zeng H, Aschner J (2007) Leptin stimulates angiogenesis in myocardial endothelial cells: Involvement of p47phox NADPH oxidase. FASEB J 21. 372.10
Xu FP, Chen MS, Wang YZ (2004) Leptin induces hypertrophy via endothelin-1–reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 110:1269–1275
Konstantinidis D, Paletas K, Koliakos G, Kaloyianni M (2009) The ambiguous role of the Na+–H+ exchanger isoform 1 (NHE1) in leptin-induced oxidative stress in human monocytes. Cell Stress and Chaperones 14:591–601
Schulz C, Paulus K, Lehnert H (2004) Central nervous and metabolic effects of intranasally applied leptin. Endocrinology 145:2696–2701
Fliedner S, Schulz C, Lehnert H (2006) Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology 147:2088–2094
Prabhakar NR (2002) Sleep apnea. An oxidative stress? Am J Respir Crit Care Med 165:859–860
Prabhakar NR (2001) Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 90:1986–1994
Jia Z, Zhu H, Misra BR, Mahaney JE, Li Y, Misra HP (2008) EPR studies on the superoxide-scavenging capacity of the nutraceutical resveratrol. Mol Cell Biochem 313:187–194
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Macrea, M., Martin, T., Zagrean, L. et al. Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method. Sleep Breath 17, 105–110 (2013). https://doi.org/10.1007/s11325-012-0656-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-012-0656-8